NCT00074477View on ClinicalTrials.gov

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

July 31, 2004

Conditions
Schizophrenia
Interventions
DRUG

R092670

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00074477 - Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter